Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.8721
-0.0302 (-3.35%)
At close: Aug 8, 2025, 4:00 PM
0.8900
+0.0179 (2.05%)
After-hours: Aug 8, 2025, 7:58 PM EDT
Satixfy Communications Employees
Immunic had 91 employees as of December 31, 2024. The number of employees increased by 14 or 18.18% compared to the previous year.
Employees
91
Change (1Y)
14
Growth (1Y)
18.18%
Revenue / Employee
n/a
Profits / Employee
-$1,059,297
Market Cap
86.03M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 91 | 14 | 18.18% |
| Dec 31, 2023 | 77 | 11 | 16.67% |
| Dec 31, 2022 | 66 | 11 | 20.00% |
| Dec 31, 2021 | 55 | 27 | 96.43% |
| Dec 31, 2020 | 28 | 2 | 7.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IMUX News
- 3 days ago - Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 6 weeks ago - Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis - PRNewsWire
- 2 months ago - Immunic Post-Readout: Reiterating Strong Buy As Big Drop Appears Unwarranted - Seeking Alpha
- 2 months ago - Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS - PRNewsWire
- 2 months ago - Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering - PRNewsWire
- 2 months ago - Immunic to Participate in Investor, Scientific and Industry Conferences in June - PRNewsWire
- 2 months ago - Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering - PRNewsWire
- 2 months ago - Immunic, Inc. Announces Proposed Public Offering - PRNewsWire